SCHEMBL899615

SCHEMBL899615

CCCCOC(=O)N1CCN(c2cnc([N+](=O)[O-])c(N)c2)CC1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 7/20 0.48
KMT2A Q03164 4/20 0.48
MEN1 O00255 3/20 0.48
CYP1A2 P05177 1/20 0.48
CYP2C9 P11712 1/20 0.48
CYP2C19 P33261 1/20 0.48
LMNA P02545 4/20 0.47
ALDH1A1 P00352 3/20 0.47
SMN1; SMN2 Q16637 3/20 0.47
GPR174 Q9BXC1 3/20 0.42
HRH2 P25021 3/20 0.40
HRH1 P35367 3/20 0.40
HPGD P15428 1/20 0.40
L3MBTL1 Q9Y468 1/20 0.39
POLB P06746 1/20 0.39
NPC1 O15118 1/20 0.39
MTOR P42345 1/20 0.39
RAB9A P51151 1/20 0.39
MET P08581 1/20 0.39
KDM4E B2RXH2 2/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL899935 0.81 MAPT (0.58) MAPTKMT2AMEN1CYP1A2CYP2C9
SCHEMBL28615895 0.80 SMN1; SMN2 (0.48) MAPTKMT2ALMNAALDH1A1SMN1; SMN2
SCHEMBL29742046 0.80 MAPT (0.58) MAPTKMT2ALMNAALDH1A1SMN1; SMN2
SCHEMBL27927938 0.79 MAPT (0.42) MAPTKMT2AMEN1CYP1A2CYP2C9
SCHEMBL27694790 0.77 MAPT (0.49) MAPTKMT2ALMNAALDH1A1SMN1; SMN2
SCHEMBL27464372 0.76 MAPT (0.79) MAPTKMT2AMEN1LMNAALDH1A1
SCHEMBL20524642 0.76 MAPT (0.44) MAPTKMT2AMEN1CYP1A2CYP2C9
SCHEMBL25263883 0.74 SIRT6 (0.60) MAPTKMT2AMEN1LMNAALDH1A1
SCHEMBL29742079 0.74 MAPT (0.55) MAPTKMT2AMEN1CYP1A2CYP2C9
SCHEMBL15569212 0.72 MAPT (0.50) MAPTLMNAALDH1A1SMN1; SMN2HRH2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2621920-A1 NOVEL PIPERAZINE ANALOGS WITH SUBSTITUTED HETEROARYL GROUPS AS BROAD-SPECTRUM INFLUENZA ANTIVIRALS Bristol-Myers Squibb Company (US) 2013-08-07 EP disclosed
WO-2012044531-A1 NOVEL PIPERAZINE ANALOGS WITH SUBSTITUTED HETEROARYL GROUPS AS BROAD-SPECTRUM INFLUENZA ANTIVIRALS BRISTOL-MYERS SQUIBB COMPANY (US) 2012-04-05 WO disclosed